Parallel Advisors, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,251
+7.9%
560.0%0.00%
Q2 2023$3,014
+35.5%
560.0%0.00%
Q1 2023$2,224
-1.3%
560.0%0.00%
Q4 2022$2,253
+12.6%
56
-6.7%
0.00%
Q3 2022$2,000
+100.0%
60
+140.0%
0.00%
Q2 2018$1,0000.0%250.0%0.00%
Q1 2018$1,000
-50.0%
250.0%0.00%
Q4 2017$2,0000.0%250.0%0.00%
Q3 2017$2,000
+100.0%
250.0%0.00%
Q2 2017$1,000250.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders